Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.
-
He AR, Smith CI, Cruz-Correa M, Chakraborty R, Zhang S, Sang S, Cheng G, Hecht SS, Bazzi LA, Kocherginsky M, Benante KA, Schering T, Richmond E, Rodriguez LM, Khan SA, Chung FL. A Phase I Dose-Escalation Study of Polyphenon E in Liver Cirrhosis: Evaluation of Safety and Effect on Liver ?-OHPdG Levels. Cancer Prev Res (Phila). 2025 Oct 01; 18(10):635-646.
-
Yamada A, Watanabe A, Nara A, Ishimaru N, Maeda K, Ido Y, Kotake K, Asano M, Shinohara Y, Yamamoto T. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. Int J Mol Sci. 2024 Jun 04; 25(11).
-
Diwan R, Gaytan SL, Bhatt HN, Pena-Zacarias J, Nurunnabi M. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Deliv Transl Res. 2024 10; 14(10):2743-2770.
-
Bangaru S, Sundaresh R, Lee A, Prause N, Hao F, Dong TS, Tincopa M, Cholankeril G, Rich NE, Kawamoto J, Bhattacharya D, Han SB, Patel AA, Shaheen M, Benhammou JN. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records. Dig Dis Sci. 2023 12; 68(12):4474-4484.
-
Kanwal F, Nelson R, Liu Y, Kramer JR, Hernaez R, Cholankeril G, Rana A, Flores A, Smith D, Cao Y, Beech B, Asch SM. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
-
Hang Y, Lee C, Roman YM. Assessing the clinical utility of major indices for nonalcoholic fatty liver disease in East?Asian populations. Biomark Med. 2023 04; 17(8):445-454.
-
Pan CC, Maeso-D?az R, Lewis TR, Xiang K, Tan L, Liang Y, Wang L, Yang F, Yin T, Wang C, Du K, Oh SH, Wang E, Lim BJW, Chong M, Alexander PB, Yao X, Arshavsky VY, Li QJ, Diehl AM, Wang XF. Antagonizing the irreversible thrombomodulin-initiated proteolytic signaling alleviates age-related liver fibrosis via senescent cell killing. Cell Res. 2023 07; 33(7):516-532.
-
Makrogiannis S. Editorial for "Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated from the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis". J Magn Reson Imaging. 2023 11; 58(5):1579.
-
Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang JY. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. Int J Mol Sci. 2023 Feb 13; 24(4).
-
Rabiee A, Gay MD, Shivapurkar N, Cao H, Nadella S, Smith CI, Lewis JH, Bansal S, Cheema A, Kwagyan J, Smith JP. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis. Clin Pharmacol Ther. 2022 12; 112(6):1271-1279.